Lv11
100 积分 2022-08-24 加入
The epidemiological landscape of multiple myeloma: a global cancer registry estimate of disease burden, risk factors, and temporal trends
4天前
已完结
Talquetamab plus Teclistamab in Relapsed or Refractory Multiple Myeloma
15天前
已完结
Review of the 2021 Resuscitation Council United Kingdom guideline for the emergency treatment of anaphylaxis
19天前
已完结
Definition and initial validation of a Lupus Low Disease Activity State (LLDAS)
26天前
已完结
The race to reset autoimmune diseases
1个月前
已完结
First-in-human trial of the safety, pharmacokinetics and immunogenicity of a PEGylated anti-CD40L antibody fragment (CDP7657) in healthy individuals and patients with systemic lupus erythematosus
1个月前
已完结
Adverse Effects of Immunosuppression: Infections
1个月前
已完结
Sequential immunotherapy: towards cures for autoimmunity
2个月前
已完结
Telitacicept: First Approval
2个月前
已完结
Trends in the drug target landscape for autoimmune diseases
2个月前
已完结
皖公网安备34019202002308
